Cargando…
Levels of PEDF in Pleural Effusions from Lung Adenocarcinoma and Benign Disease Patients
Anti-tumor properties assigned to PEDF, beside its role as an inhibitor of angiogenesis, make it a promising candidate in the search of new biomarkers for malignancy. In this study levels of PEDF were investigated in pleural effusions from lung adenocarcinoma and benign inflammatory disease patients...
Autores principales: | Sánchez-Otero, Nuria, Blanco-Prieto, Sonia, Vázquez-Iglesias, Lorena, de la Cadena, María Páez, Fernández-Villar, Alberto, Botana-Rial, María Isabel, Rodríguez-Berrocal, Francisco Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809976/ https://www.ncbi.nlm.nih.gov/pubmed/23594561 http://dx.doi.org/10.3233/DMA-130990 |
Ejemplares similares
-
Calprotectin: a novel biomarker for the diagnosis of pleural effusion
por: Sánchez-Otero, N, et al.
Publicado: (2012) -
Evaluation of pleural effusion sCD26 and DPP-IV as diagnostic biomarkers in lung disease
por: Sánchez-Otero, Nuria, et al.
Publicado: (2014) -
Validation of Calprotectin As a Novel Biomarker For The Diagnosis of Pleural Effusion: a Multicentre Trial
por: Botana-Rial, Maribel, et al.
Publicado: (2020) -
Serum Calprotectin, CD26 and EGF to Establish a Panel for the Diagnosis of Lung Cancer
por: Blanco-Prieto, Sonia, et al.
Publicado: (2015) -
Highly Sensitive Marker Panel for Guidance in Lung Cancer Rapid Diagnostic Units
por: Blanco-Prieto, Sonia, et al.
Publicado: (2017)